Erratum: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis (Journal of Clinical Investigation (2003) 112 (503-516) doi:10.1172/JCI200317913);Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis

Journal of Clinical Investigation

Volumn 112, Issue 4, 2003, Pages 503-516

  Li, Yingjian ^a   Yang, Junwei ^a   Dai, Chunsun ^a   Wu, Chuanyue ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GELATINASE A; INTEGRIN LINKED KINASE; MATRIGEL; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; ANDROSTANE DERIVATIVE; BIOMATERIAL; COLLAGEN; DNA BINDING PROTEIN; ENZYME INHIBITOR; GELATINASE B; INTEGRIN-LINKED KINASE; LAMININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; PROTEOGLYCAN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD2 PROTEIN, MOUSE; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; DOSE RESPONSE; EPITHELIAL TO MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL INTERSTITIAL FIBROGENESIS; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL MOTION; DOMINANT GENE; DRUG COMBINATION; EPITHELIUM; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; KIDNEY DISEASE; MALE; MESODERM; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; PLASMID; TIME; WESTERN BLOTTING;

ANDROSTADIENES; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; COLLAGEN; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME INHIBITORS; EPITHELIUM; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, DOMINANT; HUMANS; KIDNEY DISEASES; LAMININ; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESODERM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0141720342     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317913C1     Document Type: Erratum

References (55)

1. Strutz, F., and Muller, G.A. 2000. Transdifferentiation comes of age. Nephrol. Dial. Transplant. 15:1729-1731.
2. Yang, J., and Liu, Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159:1465-1475.
3. Iwano, M., et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350. doi:10.1172/JCI200215518.
4. Yang, J., et al. 2002. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J. Clin. Invest. 110:1525-1538. doi:10.1172/JCI200216219.
5. Zeisberg, M., et al. 2001. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol. 159:1313-1321.
6. Yang, J., and Liu, Y. 2002. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13:96-107.
7. Okada, H., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1997. Early role of Fspl in epithelial-mesenchymal transformation. Am. J. Physiol. 273:F563-F574.
8. Fan, J.M., et al. 1999. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56:1455-1467.
9. Strutz, F., et al. 2002. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 61:1714-1728.
10. Yang, J., Dai, C., and Liu, Y. 2002. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J. Am. Soc. Nephrol. 13:2464-2477.
11. Border, W.A., and Noble, N.A. 1997. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int. 51:1388-1396.
12. Bottinger, E.P., and Bitzer, M. 2002. TGF-β1 signaling in renal disease. J. Am. Soc. Nephrol. 13:2600-2610.
13. Schnaper, H.W., Hayashida, T., Hubchak, S.C., and Poncelet, A.C. 2003. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 284:F243-F252.
14. Eddy, A.A. 2000. Molecular basis of renal fibrosis. Pediatr. Nephrol. 15:290-301.
15. Sutaria, P.M., Ohebshalom, M., McCaffrey, T.A., Vaughan, E.D., Jr., and Felsen, D. 1998. Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci. 62:1965-1972.
16. Wu, C. 2001. ILK interactions. J. Cell Sci. 114:2549-2550.
17. Wu, C., and Dedhar, S. 2001. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 155:505-510.
18. Dedhar, S., Williams, B., and Hannigan, G. 1999. Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol. 9:319-323.
19. Dedhar, S. 2000. Cell-substrate interactions and signaling through ILK. Curr. Opin. Cell Biol. 12:250-256.
20. Wu, C., et al. 1998. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J. Biol. Chem. 273:528-536.
21. Kretzler, M., et al. 2001. Integrin-linked kinase as a as a candidate downstream effector in proteinuria. FASEB J 15:1843-1845.
22. Guo, L., Sanders, P.W., Woods, A., and Wu, C. 2001. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am. J. Pathol. 159:1735-1742.
23. Nakao, A., et al. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:631-635.
24. Batlle, E., et al. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:84-89.
25. Racusen, L.C., et al. 1997. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J. Lab. Clin. Med. 129:318-329.
26. Liu, Y. 1999. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am. J. Physiol. 277:F624-F633.
27. Dai, C., Yang, J., and Liu, Y. 2003. Transforming growth factor-β1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J. Biol. Chem. 278:12537-12545.
28. Oda, T., et al. 2001. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int. 60:587-596.
29. Klahr, S., and Morrissey, J. 2002. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 283:F861-F875.
30. Sato, Y., et al. 1995. Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes. Diabetes Res. Clin. Pract. 29:153-161.
31. Liu, Y., et al. 1999. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 55:442-453.
32. Jockusch, B.M., et al. 1995. The molecular architecture of focal adhesions. Annu. Rev. Cell Dev. Biol. 11:379-416.
33. Janji, B., Melchior, C., Vallar, L., and Kieffer, N. 2000. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation. Oncogene. 19:3069-3077.
34. Dennler, S., Goumans, M.J., and ten Dijke, P. 2002. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 71:731-740.
35. Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169-178.
36. Li, J.H., et al. 2002. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking smad2 activation. J. Am. Soc. Nephrol. 13:1464-1472.
37. Bhowmick, N.A., et al. 2001. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12:27-36.
38. Kaartinen, V., Haataja, L., Nagy, A., Heisterkamp, N., and Groffen, J. 2002. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis. Int. J. Mol. Med. 9:563-570.
39. Guo, L., and Wu, C. 2002. Regulation of fibronectin matrix, deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J. 16:1298-1300.
40. Tu, Y., Huang, Y., Zhang, Y., Hua, Y., and Wu, C. 2001. A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J. Cell Biol. 153:585-598.
41. Nikolopoulos, S.N., and Turner, C.E. 2002. Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization. J. Biol. Chem. 277:1568-1575.
42. White, D.E., Cardiff, R.D., Dedhar, S., and Muller, W.J. 2001 Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene. 20:7064-7072.
43. Horster, M.F., Braun, G.S., and Huber, S.M. 1999. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol. Rev. 79:1157-1191.
44. Steinberg, M.S., and McNutt, P.M. 1999. Cadherins and their connections: adhesion junctions have broader functions. Curr. Opin. Cell Biol. 11:554-560.
45. Knust E., and Bossinger, O. 2002. Composition and formation of intercellular junctions in epithelial cells. Science. 298:1955-1959.
46. Cano, A., et al. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol 2:76-83.
47. Tan, C., et al. 2001. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene. 20:133-140.
48. Christopher, R.A., Kowalczyk, A.P., and McKeown-Longo, P.J. 1997. Localization of fibronectin matrix assembly sites on fibroblasts and endothelial cells. J. Cell Sci. 110:569-581.
49. Pankov, R., et al. 2000. Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J. Cell Biol. 148:1075-1090.
50. Pankov, R., and Yamada, KM. 2002. Fibronectin at a glance. J. Cell Sci. 115:3861-3863.
51. Wu, C., Keivens, V.M., O'Toole, T.E., McDonald, J.A., and Ginsberg, M.H. 1995. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell. 83:715-724.
52. Troussard, A.A., et al. 2000. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene. 19:5444-5452.
53. Deng, J.T., Van Lierop, J.E., Sutherland, C., and Walsh, M.P. 2001. Ca2+-independent smooth muscle contraction. A novel function for integrin-linked kinase. J. Biol. Chem. 276:16365-16373.
54. Oldfield, M.D., et al. 2001. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Invest. 108:1853-1863. doi:10.1172/JCI200111951.
55. Yoganathan, N., et al. 2002. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties. Pharmacol. Ther. 93:233-242.